Sustainable Development Strategies Can Reduce Global Antimicrobial Resistance
By Elana Gotkine HealthDay Reporter
WEDNESDAY, May 7, 2025 -- Sustainable development strategies are important for helping low- and middle-income countries to address the dual challenges of climate change and antimicrobial resistance (AMR), according to a study published online April 28 in Nature Medicine.
Weibin Li, from the School of Public Health at Sun Yat-sen University in Guangzhou, China, and colleagues analyzed the impact of socioeconomic and environmental factors on AMR using 4,502 AMR surveillance records involving 32 million tested isolates from 101 countries for 1999 to 2022. Forecast models were established based on several scenarios, considering a reduction in antimicrobial consumption, sustainable development initiatives, and different shared socioeconomic pathways under climate change.
Under different shared socioeconomic pathway scenarios, the researchers identified growing AMR disparities between high-income countries and low- and middle-income countries. Compared with baseline, by 2050, the most prominent effect was seen for sustainable development efforts, which reduced the prevalence of AMR by 5.1 percent, surpassing the effect of a reduction in antimicrobial consumption. Reducing out-of-pocket health expenses, comprehensive immunization coverage, adequate health investments, and universal access to water, sanitation, and hygiene services were key contributors (3.6, 1.2, 0.2, and 0.1 percent, respectively).
"Addressing the complex relationship between climate change, human activities, and AMR requires ongoing research, policy development, and the implementation of targeted interventions," the authors write. "A multifaceted and collaborative approach is critical to effectively managing AMR and safeguarding global public health."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Canagliflozin Tied to Reduction in HbA1c in Children, Teens With T2DM
WEDNESDAY, Aug. 6, 2025 -- Canagliflozin is associated with a clinically meaningful reduction in hemoglobin A1c (HbA1c) for children and adolescents with type 2 diabetes mellitus...
About One in Six Men With Grade Group 1 Prostate Cancer Has Intermediate-, High-Risk Disease
WEDNESDAY, Aug. 6, 2025 -- A proportion of men with grade group 1 (GG1) prostate cancer have a higher-risk disease than suggested by biopsy, according to a study published online...
Follow-Up on Blood-Based Colorectal Cancer Screening Results Is Low
TUESDAY, Aug. 5, 2025 -- Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up colonoscopy (FU-CY) within...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.